nodes	percent_of_prediction	percent_of_DWPC	metapath
L-Carnitine—CPT1A—type 2 diabetes mellitus	0.383	1	CbGaD
L-Carnitine—CPT1A—Glyburide—type 2 diabetes mellitus	0.194	0.556	CbGbCtD
L-Carnitine—SLCO1B1—Repaglinide—type 2 diabetes mellitus	0.0398	0.114	CbGbCtD
L-Carnitine—SLCO1B1—Pioglitazone—type 2 diabetes mellitus	0.036	0.103	CbGbCtD
L-Carnitine—SLCO1B1—Rosiglitazone—type 2 diabetes mellitus	0.0332	0.095	CbGbCtD
L-Carnitine—SLCO1B1—Valsartan—type 2 diabetes mellitus	0.0294	0.0839	CbGbCtD
L-Carnitine—SLCO1B1—Losartan—type 2 diabetes mellitus	0.0169	0.0482	CbGbCtD
L-Carnitine—SLC25A29—islet of Langerhans—type 2 diabetes mellitus	0.00197	0.0393	CbGeAlD
L-Carnitine—SLC22A16—kidney—type 2 diabetes mellitus	0.00177	0.0353	CbGeAlD
L-Carnitine—SLC25A20—islet of Langerhans—type 2 diabetes mellitus	0.00157	0.0313	CbGeAlD
L-Carnitine—CRAT—islet of Langerhans—type 2 diabetes mellitus	0.00153	0.0304	CbGeAlD
L-Carnitine—CROT—nephron tubule—type 2 diabetes mellitus	0.00146	0.029	CbGeAlD
L-Carnitine—SLC25A29—pancreas—type 2 diabetes mellitus	0.00139	0.0276	CbGeAlD
L-Carnitine—SLC25A20—nephron tubule—type 2 diabetes mellitus	0.00127	0.0252	CbGeAlD
L-Carnitine—SLC25A29—adipose tissue—type 2 diabetes mellitus	0.00126	0.0251	CbGeAlD
L-Carnitine—CROT—cortex of kidney—type 2 diabetes mellitus	0.00125	0.0248	CbGeAlD
L-Carnitine—CPT1A—islet of Langerhans—type 2 diabetes mellitus	0.00124	0.0246	CbGeAlD
L-Carnitine—CRAT—nephron tubule—type 2 diabetes mellitus	0.00123	0.0245	CbGeAlD
L-Carnitine—MPO—artery—type 2 diabetes mellitus	0.00121	0.0241	CbGeAlD
L-Carnitine—CROT—adipose tissue—type 2 diabetes mellitus	0.00115	0.023	CbGeAlD
L-Carnitine—SLC25A20—cardiovascular system—type 2 diabetes mellitus	0.00114	0.0227	CbGeAlD
L-Carnitine—SLC25A20—pancreas—type 2 diabetes mellitus	0.00111	0.022	CbGeAlD
L-Carnitine—CRAT—cardiovascular system—type 2 diabetes mellitus	0.0011	0.022	CbGeAlD
L-Carnitine—SLC25A20—cortex of kidney—type 2 diabetes mellitus	0.00108	0.0216	CbGeAlD
L-Carnitine—CRAT—kidney—type 2 diabetes mellitus	0.00108	0.0215	CbGeAlD
L-Carnitine—CRAT—pancreas—type 2 diabetes mellitus	0.00107	0.0214	CbGeAlD
L-Carnitine—CRAT—cortex of kidney—type 2 diabetes mellitus	0.00105	0.021	CbGeAlD
L-Carnitine—MPO—endothelium—type 2 diabetes mellitus	0.00102	0.0204	CbGeAlD
L-Carnitine—CPT2—retina—type 2 diabetes mellitus	0.001	0.02	CbGeAlD
L-Carnitine—SLC25A20—adipose tissue—type 2 diabetes mellitus	0.001	0.02	CbGeAlD
L-Carnitine—CRAT—adipose tissue—type 2 diabetes mellitus	0.000973	0.0194	CbGeAlD
L-Carnitine—CPT2—nephron tubule—type 2 diabetes mellitus	0.000945	0.0188	CbGeAlD
L-Carnitine—CPT1A—cardiovascular system—type 2 diabetes mellitus	0.000894	0.0178	CbGeAlD
L-Carnitine—SLC25A29—liver—type 2 diabetes mellitus	0.000882	0.0176	CbGeAlD
L-Carnitine—CPT1A—kidney—type 2 diabetes mellitus	0.000875	0.0174	CbGeAlD
L-Carnitine—CPT1A—pancreas—type 2 diabetes mellitus	0.000869	0.0173	CbGeAlD
L-Carnitine—CPT2—cardiovascular system—type 2 diabetes mellitus	0.000849	0.0169	CbGeAlD
L-Carnitine—CPT2—kidney—type 2 diabetes mellitus	0.00083	0.0166	CbGeAlD
L-Carnitine—CPT2—cortex of kidney—type 2 diabetes mellitus	0.000809	0.0161	CbGeAlD
L-Carnitine—CROT—liver—type 2 diabetes mellitus	0.000809	0.0161	CbGeAlD
L-Carnitine—CPT1A—adipose tissue—type 2 diabetes mellitus	0.000789	0.0157	CbGeAlD
L-Carnitine—CPT2—adipose tissue—type 2 diabetes mellitus	0.000748	0.0149	CbGeAlD
L-Carnitine—SLC25A20—liver—type 2 diabetes mellitus	0.000703	0.014	CbGeAlD
L-Carnitine—CRAT—liver—type 2 diabetes mellitus	0.000682	0.0136	CbGeAlD
L-Carnitine—XDH—kidney—type 2 diabetes mellitus	0.000647	0.0129	CbGeAlD
L-Carnitine—CPT1A—liver—type 2 diabetes mellitus	0.000553	0.011	CbGeAlD
L-Carnitine—CPT2—liver—type 2 diabetes mellitus	0.000525	0.0105	CbGeAlD
L-Carnitine—CES1—cardiovascular system—type 2 diabetes mellitus	0.000504	0.01	CbGeAlD
L-Carnitine—CES1—adipose tissue—type 2 diabetes mellitus	0.000445	0.00886	CbGeAlD
L-Carnitine—SLC22A4—nephron tubule—type 2 diabetes mellitus	0.000428	0.00853	CbGeAlD
L-Carnitine—SLCO1B1—kidney—type 2 diabetes mellitus	0.000424	0.00844	CbGeAlD
L-Carnitine—MPO—cardiovascular system—type 2 diabetes mellitus	0.000421	0.00839	CbGeAlD
L-Carnitine—MPO—kidney—type 2 diabetes mellitus	0.000412	0.00821	CbGeAlD
L-Carnitine—MPO—pancreas—type 2 diabetes mellitus	0.000409	0.00815	CbGeAlD
L-Carnitine—XDH—liver—type 2 diabetes mellitus	0.000409	0.00815	CbGeAlD
L-Carnitine—SLC22A4—kidney—type 2 diabetes mellitus	0.000376	0.0075	CbGeAlD
L-Carnitine—SLC22A8—nephron tubule—type 2 diabetes mellitus	0.000375	0.00747	CbGeAlD
L-Carnitine—SLC22A4—cortex of kidney—type 2 diabetes mellitus	0.000366	0.0073	CbGeAlD
L-Carnitine—SLC22A4—adipose tissue—type 2 diabetes mellitus	0.000339	0.00676	CbGeAlD
L-Carnitine—SLC22A8—kidney—type 2 diabetes mellitus	0.000329	0.00656	CbGeAlD
L-Carnitine—SLC22A8—cortex of kidney—type 2 diabetes mellitus	0.000321	0.00639	CbGeAlD
L-Carnitine—CES1—liver—type 2 diabetes mellitus	0.000312	0.00621	CbGeAlD
L-Carnitine—SLC22A5—retina—type 2 diabetes mellitus	0.000301	0.00599	CbGeAlD
L-Carnitine—SLC22A5—nephron tubule—type 2 diabetes mellitus	0.000283	0.00564	CbGeAlD
L-Carnitine—SLCO1B1—liver—type 2 diabetes mellitus	0.000268	0.00534	CbGeAlD
L-Carnitine—MPO—liver—type 2 diabetes mellitus	0.00026	0.00519	CbGeAlD
L-Carnitine—SLC22A5—kidney—type 2 diabetes mellitus	0.000249	0.00496	CbGeAlD
L-Carnitine—SLC22A5—cortex of kidney—type 2 diabetes mellitus	0.000242	0.00483	CbGeAlD
L-Carnitine—SLC22A5—adipose tissue—type 2 diabetes mellitus	0.000224	0.00447	CbGeAlD
L-Carnitine—SLC22A5—liver—type 2 diabetes mellitus	0.000157	0.00314	CbGeAlD
L-Carnitine—Body temperature increased—Bromocriptine—type 2 diabetes mellitus	0.000128	0.00114	CcSEcCtD
L-Carnitine—Abdominal pain—Bromocriptine—type 2 diabetes mellitus	0.000128	0.00114	CcSEcCtD
L-Carnitine—Gastrointestinal disorder—Glyburide—type 2 diabetes mellitus	0.000128	0.00114	CcSEcCtD
L-Carnitine—Chest pain—Valsartan—type 2 diabetes mellitus	0.000128	0.00114	CcSEcCtD
L-Carnitine—Myalgia—Valsartan—type 2 diabetes mellitus	0.000128	0.00114	CcSEcCtD
L-Carnitine—Dizziness—Glipizide—type 2 diabetes mellitus	0.000127	0.00114	CcSEcCtD
L-Carnitine—Pruritus—Glimepiride—type 2 diabetes mellitus	0.000127	0.00114	CcSEcCtD
L-Carnitine—Anxiety—Valsartan—type 2 diabetes mellitus	0.000127	0.00114	CcSEcCtD
L-Carnitine—Angiopathy—Losartan—type 2 diabetes mellitus	0.000126	0.00113	CcSEcCtD
L-Carnitine—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.000126	0.00113	CcSEcCtD
L-Carnitine—Dysgeusia—Irbesartan—type 2 diabetes mellitus	0.000126	0.00113	CcSEcCtD
L-Carnitine—Chest pain—Orlistat—type 2 diabetes mellitus	0.000126	0.00113	CcSEcCtD
L-Carnitine—Myalgia—Orlistat—type 2 diabetes mellitus	0.000126	0.00113	CcSEcCtD
L-Carnitine—Anxiety—Orlistat—type 2 diabetes mellitus	0.000126	0.00112	CcSEcCtD
L-Carnitine—Sinusitis—Ramipril—type 2 diabetes mellitus	0.000125	0.00111	CcSEcCtD
L-Carnitine—Hypotension—Gliclazide—type 2 diabetes mellitus	0.000124	0.00111	CcSEcCtD
L-Carnitine—Arrhythmia—Losartan—type 2 diabetes mellitus	0.000124	0.00111	CcSEcCtD
L-Carnitine—Muscle spasms—Irbesartan—type 2 diabetes mellitus	0.000124	0.00111	CcSEcCtD
L-Carnitine—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.000123	0.0011	CcSEcCtD
L-Carnitine—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.000123	0.00109	CcSEcCtD
L-Carnitine—Vomiting—Glipizide—type 2 diabetes mellitus	0.000122	0.00109	CcSEcCtD
L-Carnitine—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000122	0.00109	CcSEcCtD
L-Carnitine—Infection—Valsartan—type 2 diabetes mellitus	0.000122	0.00108	CcSEcCtD
L-Carnitine—Rash—Glipizide—type 2 diabetes mellitus	0.000121	0.00108	CcSEcCtD
L-Carnitine—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000121	0.00108	CcSEcCtD
L-Carnitine—Musculoskeletal discomfort—Gliclazide—type 2 diabetes mellitus	0.000121	0.00108	CcSEcCtD
L-Carnitine—Gastrointestinal pain—Glyburide—type 2 diabetes mellitus	0.000121	0.00108	CcSEcCtD
L-Carnitine—Headache—Glipizide—type 2 diabetes mellitus	0.000121	0.00108	CcSEcCtD
L-Carnitine—Palpitations—Metformin—type 2 diabetes mellitus	0.000121	0.00108	CcSEcCtD
L-Carnitine—Insomnia—Gliclazide—type 2 diabetes mellitus	0.00012	0.00108	CcSEcCtD
L-Carnitine—Infection—Orlistat—type 2 diabetes mellitus	0.00012	0.00107	CcSEcCtD
L-Carnitine—Paraesthesia—Gliclazide—type 2 diabetes mellitus	0.00012	0.00107	CcSEcCtD
L-Carnitine—Anaemia—Irbesartan—type 2 diabetes mellitus	0.000119	0.00106	CcSEcCtD
L-Carnitine—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000119	0.00106	CcSEcCtD
L-Carnitine—Dysgeusia—Losartan—type 2 diabetes mellitus	0.000119	0.00106	CcSEcCtD
L-Carnitine—Dyspnoea—Gliclazide—type 2 diabetes mellitus	0.000119	0.00106	CcSEcCtD
L-Carnitine—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000118	0.00106	CcSEcCtD
L-Carnitine—Hypertension—Metformin—type 2 diabetes mellitus	0.000118	0.00105	CcSEcCtD
L-Carnitine—Oedema peripheral—Ramipril—type 2 diabetes mellitus	0.000118	0.00105	CcSEcCtD
L-Carnitine—Back pain—Losartan—type 2 diabetes mellitus	0.000117	0.00105	CcSEcCtD
L-Carnitine—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.000117	0.00105	CcSEcCtD
L-Carnitine—Dyspepsia—Gliclazide—type 2 diabetes mellitus	0.000117	0.00105	CcSEcCtD
L-Carnitine—Anorexia—Valsartan—type 2 diabetes mellitus	0.000117	0.00104	CcSEcCtD
L-Carnitine—Muscle spasms—Losartan—type 2 diabetes mellitus	0.000117	0.00104	CcSEcCtD
L-Carnitine—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000116	0.00104	CcSEcCtD
L-Carnitine—Chest pain—Metformin—type 2 diabetes mellitus	0.000116	0.00104	CcSEcCtD
L-Carnitine—Myalgia—Metformin—type 2 diabetes mellitus	0.000116	0.00104	CcSEcCtD
L-Carnitine—Vertigo—Irbesartan—type 2 diabetes mellitus	0.000116	0.00103	CcSEcCtD
L-Carnitine—Headache—Pioglitazone—type 2 diabetes mellitus	0.000116	0.00103	CcSEcCtD
L-Carnitine—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.000115	0.00103	CcSEcCtD
L-Carnitine—Nausea—Glipizide—type 2 diabetes mellitus	0.000114	0.00102	CcSEcCtD
L-Carnitine—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000114	0.00102	CcSEcCtD
L-Carnitine—Hypotension—Valsartan—type 2 diabetes mellitus	0.000114	0.00102	CcSEcCtD
L-Carnitine—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000114	0.00102	CcSEcCtD
L-Carnitine—Pain—Gliclazide—type 2 diabetes mellitus	0.000114	0.00102	CcSEcCtD
L-Carnitine—Constipation—Gliclazide—type 2 diabetes mellitus	0.000114	0.00102	CcSEcCtD
L-Carnitine—Rash—Glimepiride—type 2 diabetes mellitus	0.000113	0.00101	CcSEcCtD
L-Carnitine—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000113	0.00101	CcSEcCtD
L-Carnitine—Rash—Sitagliptin—type 2 diabetes mellitus	0.000113	0.00101	CcSEcCtD
L-Carnitine—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000113	0.00101	CcSEcCtD
L-Carnitine—Headache—Glimepiride—type 2 diabetes mellitus	0.000113	0.00101	CcSEcCtD
L-Carnitine—Cough—Irbesartan—type 2 diabetes mellitus	0.000112	0.001	CcSEcCtD
L-Carnitine—Headache—Sitagliptin—type 2 diabetes mellitus	0.000112	0.001	CcSEcCtD
L-Carnitine—Anaemia—Losartan—type 2 diabetes mellitus	0.000112	0.001	CcSEcCtD
L-Carnitine—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	0.000111	0.000995	CcSEcCtD
L-Carnitine—Hypertension—Irbesartan—type 2 diabetes mellitus	0.000111	0.000993	CcSEcCtD
L-Carnitine—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000111	0.000991	CcSEcCtD
L-Carnitine—Infection—Metformin—type 2 diabetes mellitus	0.000111	0.000988	CcSEcCtD
L-Carnitine—Insomnia—Valsartan—type 2 diabetes mellitus	0.000111	0.000988	CcSEcCtD
L-Carnitine—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	0.00011	0.000983	CcSEcCtD
L-Carnitine—Paraesthesia—Valsartan—type 2 diabetes mellitus	0.00011	0.000981	CcSEcCtD
L-Carnitine—Chest pain—Irbesartan—type 2 diabetes mellitus	0.00011	0.000979	CcSEcCtD
L-Carnitine—Myalgia—Irbesartan—type 2 diabetes mellitus	0.00011	0.000979	CcSEcCtD
L-Carnitine—Insomnia—Orlistat—type 2 diabetes mellitus	0.000109	0.000976	CcSEcCtD
L-Carnitine—Anxiety—Irbesartan—type 2 diabetes mellitus	0.000109	0.000976	CcSEcCtD
L-Carnitine—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000109	0.000975	CcSEcCtD
L-Carnitine—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.000109	0.000974	CcSEcCtD
L-Carnitine—Vertigo—Losartan—type 2 diabetes mellitus	0.000109	0.000972	CcSEcCtD
L-Carnitine—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.000109	0.000972	CcSEcCtD
L-Carnitine—Paraesthesia—Orlistat—type 2 diabetes mellitus	0.000109	0.000969	CcSEcCtD
L-Carnitine—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.000108	0.000961	CcSEcCtD
L-Carnitine—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000107	0.000958	CcSEcCtD
L-Carnitine—Palpitations—Losartan—type 2 diabetes mellitus	0.000107	0.000956	CcSEcCtD
L-Carnitine—Nausea—Glimepiride—type 2 diabetes mellitus	0.000107	0.000953	CcSEcCtD
L-Carnitine—Arrhythmia—Ramipril—type 2 diabetes mellitus	0.000107	0.000952	CcSEcCtD
L-Carnitine—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000106	0.00095	CcSEcCtD
L-Carnitine—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.000106	0.00095	CcSEcCtD
L-Carnitine—Asthenia—Glyburide—type 2 diabetes mellitus	0.000106	0.00095	CcSEcCtD
L-Carnitine—Decreased appetite—Valsartan—type 2 diabetes mellitus	0.000106	0.000949	CcSEcCtD
L-Carnitine—Anorexia—Metformin—type 2 diabetes mellitus	0.000106	0.000948	CcSEcCtD
L-Carnitine—Cough—Losartan—type 2 diabetes mellitus	0.000106	0.000944	CcSEcCtD
L-Carnitine—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.000106	0.000943	CcSEcCtD
L-Carnitine—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.000105	0.00094	CcSEcCtD
L-Carnitine—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.000105	0.00094	CcSEcCtD
L-Carnitine—Decreased appetite—Orlistat—type 2 diabetes mellitus	0.000105	0.000938	CcSEcCtD
L-Carnitine—Pruritus—Glyburide—type 2 diabetes mellitus	0.000105	0.000937	CcSEcCtD
L-Carnitine—Constipation—Valsartan—type 2 diabetes mellitus	0.000105	0.000934	CcSEcCtD
L-Carnitine—Infection—Irbesartan—type 2 diabetes mellitus	0.000104	0.000932	CcSEcCtD
L-Carnitine—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.000104	0.000932	CcSEcCtD
L-Carnitine—Hypotension—Metformin—type 2 diabetes mellitus	0.000104	0.000929	CcSEcCtD
L-Carnitine—Pain—Orlistat—type 2 diabetes mellitus	0.000103	0.000923	CcSEcCtD
L-Carnitine—Myalgia—Losartan—type 2 diabetes mellitus	0.000103	0.000921	CcSEcCtD
L-Carnitine—Chest pain—Losartan—type 2 diabetes mellitus	0.000103	0.000921	CcSEcCtD
L-Carnitine—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000103	0.000921	CcSEcCtD
L-Carnitine—Anxiety—Losartan—type 2 diabetes mellitus	0.000103	0.000918	CcSEcCtD
L-Carnitine—Tachycardia—Irbesartan—type 2 diabetes mellitus	0.000103	0.000916	CcSEcCtD
L-Carnitine—Rash—Bromocriptine—type 2 diabetes mellitus	0.000102	0.000913	CcSEcCtD
L-Carnitine—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000102	0.000912	CcSEcCtD
L-Carnitine—Dysgeusia—Ramipril—type 2 diabetes mellitus	0.000102	0.000909	CcSEcCtD
L-Carnitine—Headache—Bromocriptine—type 2 diabetes mellitus	0.000102	0.000907	CcSEcCtD
L-Carnitine—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	0.000101	0.000906	CcSEcCtD
L-Carnitine—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000101	0.000906	CcSEcCtD
L-Carnitine—Anorexia—Irbesartan—type 2 diabetes mellitus	0.0001	0.000895	CcSEcCtD
L-Carnitine—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.0001	0.000893	CcSEcCtD
L-Carnitine—Paraesthesia—Metformin—type 2 diabetes mellitus	0.0001	0.000893	CcSEcCtD
L-Carnitine—Muscle spasms—Ramipril—type 2 diabetes mellitus	9.99e-05	0.000892	CcSEcCtD
L-Carnitine—Dyspnoea—Metformin—type 2 diabetes mellitus	9.93e-05	0.000887	CcSEcCtD
L-Carnitine—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	9.88e-05	0.000882	CcSEcCtD
L-Carnitine—Infection—Losartan—type 2 diabetes mellitus	9.83e-05	0.000877	CcSEcCtD
L-Carnitine—Hypotension—Irbesartan—type 2 diabetes mellitus	9.82e-05	0.000877	CcSEcCtD
L-Carnitine—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	9.81e-05	0.000876	CcSEcCtD
L-Carnitine—Dyspepsia—Metformin—type 2 diabetes mellitus	9.8e-05	0.000875	CcSEcCtD
L-Carnitine—Decreased appetite—Metformin—type 2 diabetes mellitus	9.68e-05	0.000865	CcSEcCtD
L-Carnitine—Abdominal pain—Valsartan—type 2 diabetes mellitus	9.67e-05	0.000863	CcSEcCtD
L-Carnitine—Tachycardia—Losartan—type 2 diabetes mellitus	9.65e-05	0.000862	CcSEcCtD
L-Carnitine—Nausea—Bromocriptine—type 2 diabetes mellitus	9.63e-05	0.00086	CcSEcCtD
L-Carnitine—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	9.62e-05	0.000859	CcSEcCtD
L-Carnitine—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	9.58e-05	0.000855	CcSEcCtD
L-Carnitine—Abdominal pain—Orlistat—type 2 diabetes mellitus	9.55e-05	0.000853	CcSEcCtD
L-Carnitine—Body temperature increased—Orlistat—type 2 diabetes mellitus	9.55e-05	0.000853	CcSEcCtD
L-Carnitine—Asthenia—Gliclazide—type 2 diabetes mellitus	9.55e-05	0.000853	CcSEcCtD
L-Carnitine—Constipation—Metformin—type 2 diabetes mellitus	9.52e-05	0.00085	CcSEcCtD
L-Carnitine—Paraesthesia—Irbesartan—type 2 diabetes mellitus	9.44e-05	0.000843	CcSEcCtD
L-Carnitine—Anorexia—Losartan—type 2 diabetes mellitus	9.43e-05	0.000842	CcSEcCtD
L-Carnitine—Vomiting—Glyburide—type 2 diabetes mellitus	9.43e-05	0.000842	CcSEcCtD
L-Carnitine—Pruritus—Gliclazide—type 2 diabetes mellitus	9.42e-05	0.000841	CcSEcCtD
L-Carnitine—Dyspnoea—Irbesartan—type 2 diabetes mellitus	9.37e-05	0.000837	CcSEcCtD
L-Carnitine—Rash—Glyburide—type 2 diabetes mellitus	9.35e-05	0.000835	CcSEcCtD
L-Carnitine—Dermatitis—Glyburide—type 2 diabetes mellitus	9.34e-05	0.000834	CcSEcCtD
L-Carnitine—Vertigo—Ramipril—type 2 diabetes mellitus	9.34e-05	0.000834	CcSEcCtD
L-Carnitine—Headache—Glyburide—type 2 diabetes mellitus	9.29e-05	0.000829	CcSEcCtD
L-Carnitine—Dyspepsia—Irbesartan—type 2 diabetes mellitus	9.25e-05	0.000826	CcSEcCtD
L-Carnitine—Hypotension—Losartan—type 2 diabetes mellitus	9.24e-05	0.000825	CcSEcCtD
L-Carnitine—Palpitations—Ramipril—type 2 diabetes mellitus	9.18e-05	0.00082	CcSEcCtD
L-Carnitine—Decreased appetite—Irbesartan—type 2 diabetes mellitus	9.14e-05	0.000816	CcSEcCtD
L-Carnitine—Diarrhoea—Gliclazide—type 2 diabetes mellitus	9.11e-05	0.000813	CcSEcCtD
L-Carnitine—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	9.11e-05	0.000813	CcSEcCtD
L-Carnitine—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	9.07e-05	0.00081	CcSEcCtD
L-Carnitine—Cough—Ramipril—type 2 diabetes mellitus	9.07e-05	0.00081	CcSEcCtD
L-Carnitine—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	9.01e-05	0.000805	CcSEcCtD
L-Carnitine—Hypersensitivity—Valsartan—type 2 diabetes mellitus	9.01e-05	0.000805	CcSEcCtD
L-Carnitine—Convulsion—Ramipril—type 2 diabetes mellitus	9e-05	0.000804	CcSEcCtD
L-Carnitine—Constipation—Irbesartan—type 2 diabetes mellitus	8.99e-05	0.000803	CcSEcCtD
L-Carnitine—Pain—Irbesartan—type 2 diabetes mellitus	8.99e-05	0.000803	CcSEcCtD
L-Carnitine—Insomnia—Losartan—type 2 diabetes mellitus	8.95e-05	0.000799	CcSEcCtD
L-Carnitine—Hypersensitivity—Orlistat—type 2 diabetes mellitus	8.9e-05	0.000795	CcSEcCtD
L-Carnitine—Paraesthesia—Losartan—type 2 diabetes mellitus	8.88e-05	0.000793	CcSEcCtD
L-Carnitine—Chest pain—Ramipril—type 2 diabetes mellitus	8.85e-05	0.00079	CcSEcCtD
L-Carnitine—Myalgia—Ramipril—type 2 diabetes mellitus	8.85e-05	0.00079	CcSEcCtD
L-Carnitine—Dyspnoea—Losartan—type 2 diabetes mellitus	8.82e-05	0.000787	CcSEcCtD
L-Carnitine—Anxiety—Ramipril—type 2 diabetes mellitus	8.82e-05	0.000787	CcSEcCtD
L-Carnitine—Nausea—Glyburide—type 2 diabetes mellitus	8.81e-05	0.000786	CcSEcCtD
L-Carnitine—Abdominal pain—Metformin—type 2 diabetes mellitus	8.8e-05	0.000786	CcSEcCtD
L-Carnitine—Dizziness—Gliclazide—type 2 diabetes mellitus	8.8e-05	0.000786	CcSEcCtD
L-Carnitine—Asthenia—Valsartan—type 2 diabetes mellitus	8.78e-05	0.000784	CcSEcCtD
L-Carnitine—Dyspepsia—Losartan—type 2 diabetes mellitus	8.71e-05	0.000777	CcSEcCtD
L-Carnitine—Asthenia—Orlistat—type 2 diabetes mellitus	8.67e-05	0.000774	CcSEcCtD
L-Carnitine—Pruritus—Valsartan—type 2 diabetes mellitus	8.65e-05	0.000773	CcSEcCtD
L-Carnitine—Decreased appetite—Losartan—type 2 diabetes mellitus	8.6e-05	0.000768	CcSEcCtD
L-Carnitine—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	8.59e-05	0.000767	CcSEcCtD
L-Carnitine—Pruritus—Orlistat—type 2 diabetes mellitus	8.55e-05	0.000763	CcSEcCtD
L-Carnitine—Vomiting—Gliclazide—type 2 diabetes mellitus	8.46e-05	0.000756	CcSEcCtD
L-Carnitine—Pain—Losartan—type 2 diabetes mellitus	8.46e-05	0.000755	CcSEcCtD
L-Carnitine—Constipation—Losartan—type 2 diabetes mellitus	8.46e-05	0.000755	CcSEcCtD
L-Carnitine—Rash—Gliclazide—type 2 diabetes mellitus	8.39e-05	0.000749	CcSEcCtD
L-Carnitine—Dermatitis—Gliclazide—type 2 diabetes mellitus	8.39e-05	0.000749	CcSEcCtD
L-Carnitine—Diarrhoea—Valsartan—type 2 diabetes mellitus	8.37e-05	0.000747	CcSEcCtD
L-Carnitine—Headache—Gliclazide—type 2 diabetes mellitus	8.34e-05	0.000745	CcSEcCtD
L-Carnitine—Body temperature increased—Irbesartan—type 2 diabetes mellitus	8.31e-05	0.000742	CcSEcCtD
L-Carnitine—Abdominal pain—Irbesartan—type 2 diabetes mellitus	8.31e-05	0.000742	CcSEcCtD
L-Carnitine—Tachycardia—Ramipril—type 2 diabetes mellitus	8.28e-05	0.000739	CcSEcCtD
L-Carnitine—Diarrhoea—Orlistat—type 2 diabetes mellitus	8.27e-05	0.000738	CcSEcCtD
L-Carnitine—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	8.09e-05	0.000722	CcSEcCtD
L-Carnitine—Dizziness—Valsartan—type 2 diabetes mellitus	8.09e-05	0.000722	CcSEcCtD
L-Carnitine—Anorexia—Ramipril—type 2 diabetes mellitus	8.08e-05	0.000722	CcSEcCtD
L-Carnitine—Dizziness—Orlistat—type 2 diabetes mellitus	7.99e-05	0.000714	CcSEcCtD
L-Carnitine—Asthenia—Metformin—type 2 diabetes mellitus	7.99e-05	0.000714	CcSEcCtD
L-Carnitine—Hypotension—Ramipril—type 2 diabetes mellitus	7.93e-05	0.000708	CcSEcCtD
L-Carnitine—Nausea—Gliclazide—type 2 diabetes mellitus	7.91e-05	0.000706	CcSEcCtD
L-Carnitine—Pruritus—Metformin—type 2 diabetes mellitus	7.88e-05	0.000704	CcSEcCtD
L-Carnitine—Body temperature increased—Losartan—type 2 diabetes mellitus	7.82e-05	0.000698	CcSEcCtD
L-Carnitine—Abdominal pain—Losartan—type 2 diabetes mellitus	7.82e-05	0.000698	CcSEcCtD
L-Carnitine—Vomiting—Valsartan—type 2 diabetes mellitus	7.78e-05	0.000694	CcSEcCtD
L-Carnitine—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	7.74e-05	0.000691	CcSEcCtD
L-Carnitine—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	7.73e-05	0.00069	CcSEcCtD
L-Carnitine—Rash—Valsartan—type 2 diabetes mellitus	7.71e-05	0.000689	CcSEcCtD
L-Carnitine—Dermatitis—Valsartan—type 2 diabetes mellitus	7.7e-05	0.000688	CcSEcCtD
L-Carnitine—Vomiting—Orlistat—type 2 diabetes mellitus	7.68e-05	0.000686	CcSEcCtD
L-Carnitine—Insomnia—Ramipril—type 2 diabetes mellitus	7.67e-05	0.000685	CcSEcCtD
L-Carnitine—Headache—Valsartan—type 2 diabetes mellitus	7.66e-05	0.000684	CcSEcCtD
L-Carnitine—Diarrhoea—Metformin—type 2 diabetes mellitus	7.62e-05	0.00068	CcSEcCtD
L-Carnitine—Rash—Orlistat—type 2 diabetes mellitus	7.62e-05	0.00068	CcSEcCtD
L-Carnitine—Paraesthesia—Ramipril—type 2 diabetes mellitus	7.62e-05	0.00068	CcSEcCtD
L-Carnitine—Dermatitis—Orlistat—type 2 diabetes mellitus	7.61e-05	0.00068	CcSEcCtD
L-Carnitine—Headache—Orlistat—type 2 diabetes mellitus	7.57e-05	0.000676	CcSEcCtD
L-Carnitine—Dyspnoea—Ramipril—type 2 diabetes mellitus	7.56e-05	0.000675	CcSEcCtD
L-Carnitine—Asthenia—Irbesartan—type 2 diabetes mellitus	7.54e-05	0.000673	CcSEcCtD
L-Carnitine—Dyspepsia—Ramipril—type 2 diabetes mellitus	7.47e-05	0.000667	CcSEcCtD
L-Carnitine—Pruritus—Irbesartan—type 2 diabetes mellitus	7.44e-05	0.000664	CcSEcCtD
L-Carnitine—Decreased appetite—Ramipril—type 2 diabetes mellitus	7.37e-05	0.000658	CcSEcCtD
L-Carnitine—Dizziness—Metformin—type 2 diabetes mellitus	7.37e-05	0.000658	CcSEcCtD
L-Carnitine—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	7.32e-05	0.000654	CcSEcCtD
L-Carnitine—Hypersensitivity—Losartan—type 2 diabetes mellitus	7.29e-05	0.000651	CcSEcCtD
L-Carnitine—Nausea—Valsartan—type 2 diabetes mellitus	7.26e-05	0.000649	CcSEcCtD
L-Carnitine—Constipation—Ramipril—type 2 diabetes mellitus	7.25e-05	0.000648	CcSEcCtD
L-Carnitine—Diarrhoea—Irbesartan—type 2 diabetes mellitus	7.19e-05	0.000642	CcSEcCtD
L-Carnitine—Nausea—Orlistat—type 2 diabetes mellitus	7.18e-05	0.000641	CcSEcCtD
L-Carnitine—Asthenia—Losartan—type 2 diabetes mellitus	7.1e-05	0.000634	CcSEcCtD
L-Carnitine—Vomiting—Metformin—type 2 diabetes mellitus	7.08e-05	0.000632	CcSEcCtD
L-Carnitine—Rash—Metformin—type 2 diabetes mellitus	7.02e-05	0.000627	CcSEcCtD
L-Carnitine—Dermatitis—Metformin—type 2 diabetes mellitus	7.02e-05	0.000626	CcSEcCtD
L-Carnitine—Pruritus—Losartan—type 2 diabetes mellitus	7e-05	0.000625	CcSEcCtD
L-Carnitine—Headache—Metformin—type 2 diabetes mellitus	6.98e-05	0.000623	CcSEcCtD
L-Carnitine—Dizziness—Irbesartan—type 2 diabetes mellitus	6.95e-05	0.000621	CcSEcCtD
L-Carnitine—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	6.94e-05	0.000619	CcSEcCtD
L-Carnitine—Diarrhoea—Losartan—type 2 diabetes mellitus	6.77e-05	0.000604	CcSEcCtD
L-Carnitine—Body temperature increased—Ramipril—type 2 diabetes mellitus	6.7e-05	0.000599	CcSEcCtD
L-Carnitine—Abdominal pain—Ramipril—type 2 diabetes mellitus	6.7e-05	0.000599	CcSEcCtD
L-Carnitine—Vomiting—Irbesartan—type 2 diabetes mellitus	6.68e-05	0.000597	CcSEcCtD
L-Carnitine—Rash—Irbesartan—type 2 diabetes mellitus	6.63e-05	0.000592	CcSEcCtD
L-Carnitine—Dermatitis—Irbesartan—type 2 diabetes mellitus	6.62e-05	0.000591	CcSEcCtD
L-Carnitine—Nausea—Metformin—type 2 diabetes mellitus	6.62e-05	0.000591	CcSEcCtD
L-Carnitine—Headache—Irbesartan—type 2 diabetes mellitus	6.58e-05	0.000588	CcSEcCtD
L-Carnitine—Dizziness—Losartan—type 2 diabetes mellitus	6.54e-05	0.000584	CcSEcCtD
L-Carnitine—Vomiting—Losartan—type 2 diabetes mellitus	6.29e-05	0.000562	CcSEcCtD
L-Carnitine—Hypersensitivity—Ramipril—type 2 diabetes mellitus	6.25e-05	0.000558	CcSEcCtD
L-Carnitine—Nausea—Irbesartan—type 2 diabetes mellitus	6.24e-05	0.000557	CcSEcCtD
L-Carnitine—Rash—Losartan—type 2 diabetes mellitus	6.24e-05	0.000557	CcSEcCtD
L-Carnitine—Dermatitis—Losartan—type 2 diabetes mellitus	6.23e-05	0.000556	CcSEcCtD
L-Carnitine—Headache—Losartan—type 2 diabetes mellitus	6.2e-05	0.000553	CcSEcCtD
L-Carnitine—Asthenia—Ramipril—type 2 diabetes mellitus	6.09e-05	0.000543	CcSEcCtD
L-Carnitine—Pruritus—Ramipril—type 2 diabetes mellitus	6e-05	0.000536	CcSEcCtD
L-Carnitine—Nausea—Losartan—type 2 diabetes mellitus	5.88e-05	0.000525	CcSEcCtD
L-Carnitine—Diarrhoea—Ramipril—type 2 diabetes mellitus	5.8e-05	0.000518	CcSEcCtD
L-Carnitine—Dizziness—Ramipril—type 2 diabetes mellitus	5.61e-05	0.000501	CcSEcCtD
L-Carnitine—Vomiting—Ramipril—type 2 diabetes mellitus	5.39e-05	0.000482	CcSEcCtD
L-Carnitine—Rash—Ramipril—type 2 diabetes mellitus	5.35e-05	0.000478	CcSEcCtD
L-Carnitine—Dermatitis—Ramipril—type 2 diabetes mellitus	5.34e-05	0.000477	CcSEcCtD
L-Carnitine—Headache—Ramipril—type 2 diabetes mellitus	5.31e-05	0.000474	CcSEcCtD
L-Carnitine—Nausea—Ramipril—type 2 diabetes mellitus	5.04e-05	0.00045	CcSEcCtD
L-Carnitine—CRAT—Metabolism—NOS3—type 2 diabetes mellitus	1.28e-05	0.000121	CbGpPWpGaD
L-Carnitine—SLC22A5—SLC-mediated transmembrane transport—ALB—type 2 diabetes mellitus	1.27e-05	0.000121	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—ADRA2A—type 2 diabetes mellitus	1.27e-05	0.000121	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—AANAT—type 2 diabetes mellitus	1.26e-05	0.00012	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—PTGDS—type 2 diabetes mellitus	1.26e-05	0.00012	CbGpPWpGaD
L-Carnitine—SLC22A5—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	1.26e-05	0.000119	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—CD36—type 2 diabetes mellitus	1.25e-05	0.000118	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—KCNJ11—type 2 diabetes mellitus	1.24e-05	0.000118	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—HSD3B2—type 2 diabetes mellitus	1.24e-05	0.000118	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—LPA—type 2 diabetes mellitus	1.24e-05	0.000118	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—GCKR—type 2 diabetes mellitus	1.24e-05	0.000118	CbGpPWpGaD
L-Carnitine—SLC22A8—Transmembrane transport of small molecules—PLAT—type 2 diabetes mellitus	1.24e-05	0.000118	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—PPP2CA—type 2 diabetes mellitus	1.23e-05	0.000117	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—CYP2E1—type 2 diabetes mellitus	1.22e-05	0.000116	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—CYP1A2—type 2 diabetes mellitus	1.21e-05	0.000115	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—SLC2A1—type 2 diabetes mellitus	1.21e-05	0.000115	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—CPT1A—type 2 diabetes mellitus	1.2e-05	0.000114	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—CDO1—type 2 diabetes mellitus	1.19e-05	0.000113	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—GPD2—type 2 diabetes mellitus	1.19e-05	0.000113	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—ALDOB—type 2 diabetes mellitus	1.19e-05	0.000113	CbGpPWpGaD
L-Carnitine—SLC22A8—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	1.18e-05	0.000112	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—MTHFR—type 2 diabetes mellitus	1.18e-05	0.000112	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—CYP3A4—type 2 diabetes mellitus	1.18e-05	0.000112	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	1.17e-05	0.000111	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—PTGS2—type 2 diabetes mellitus	1.17e-05	0.000111	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—PTGS2—type 2 diabetes mellitus	1.17e-05	0.000111	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—LIPC—type 2 diabetes mellitus	1.17e-05	0.000111	CbGpPWpGaD
L-Carnitine—SLCO1B1—Transmembrane transport of small molecules—SLC2A2—type 2 diabetes mellitus	1.16e-05	0.00011	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—CYP11A1—type 2 diabetes mellitus	1.16e-05	0.00011	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—SLC2A4—type 2 diabetes mellitus	1.16e-05	0.00011	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—GCG—type 2 diabetes mellitus	1.16e-05	0.00011	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—PPARA—type 2 diabetes mellitus	1.16e-05	0.00011	CbGpPWpGaD
L-Carnitine—SLC22A4—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	1.16e-05	0.00011	CbGpPWpGaD
L-Carnitine—SLC22A8—SLC-mediated transmembrane transport—ALB—type 2 diabetes mellitus	1.15e-05	0.000109	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—AK1—type 2 diabetes mellitus	1.14e-05	0.000108	CbGpPWpGaD
L-Carnitine—SLC22A8—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	1.14e-05	0.000108	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—CETP—type 2 diabetes mellitus	1.12e-05	0.000107	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—AGT—type 2 diabetes mellitus	1.12e-05	0.000107	CbGpPWpGaD
L-Carnitine—SLCO1B1—Transmembrane transport of small molecules—ATP2A2—type 2 diabetes mellitus	1.11e-05	0.000105	CbGpPWpGaD
L-Carnitine—SLCO1B1—Transmembrane transport of small molecules—GCK—type 2 diabetes mellitus	1.11e-05	0.000105	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—GLP1R—type 2 diabetes mellitus	1.11e-05	0.000105	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—CALM1—type 2 diabetes mellitus	1.1e-05	0.000105	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—APOE—type 2 diabetes mellitus	1.1e-05	0.000104	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—APOA1—type 2 diabetes mellitus	1.09e-05	0.000103	CbGpPWpGaD
L-Carnitine—SLC22A4—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	1.09e-05	0.000103	CbGpPWpGaD
L-Carnitine—SLC22A5—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	1.08e-05	0.000103	CbGpPWpGaD
L-Carnitine—SLCO1B1—Transmembrane transport of small molecules—SLC9A1—type 2 diabetes mellitus	1.08e-05	0.000103	CbGpPWpGaD
L-Carnitine—SLC22A5—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	1.08e-05	0.000102	CbGpPWpGaD
L-Carnitine—SLCO1B1—Transmembrane transport of small molecules—TRPC6—type 2 diabetes mellitus	1.08e-05	0.000102	CbGpPWpGaD
L-Carnitine—SLCO1B1—Transmembrane transport of small molecules—CETP—type 2 diabetes mellitus	1.07e-05	0.000102	CbGpPWpGaD
L-Carnitine—SLC22A5—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	1.07e-05	0.000101	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—SLC5A4—type 2 diabetes mellitus	1.05e-05	9.97e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—MAT1A—type 2 diabetes mellitus	1.05e-05	9.97e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—SREBF1—type 2 diabetes mellitus	1.05e-05	9.93e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—SLC2A2—type 2 diabetes mellitus	1.03e-05	9.81e-05	CbGpPWpGaD
L-Carnitine—SLC22A5—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	1.03e-05	9.8e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—CTGF—type 2 diabetes mellitus	1.03e-05	9.75e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—HMGCR—type 2 diabetes mellitus	1.02e-05	9.66e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—ND1—type 2 diabetes mellitus	1.01e-05	9.63e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—PPP1R3C—type 2 diabetes mellitus	1.01e-05	9.63e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—G6PC—type 2 diabetes mellitus	1.01e-05	9.63e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—ENPP1—type 2 diabetes mellitus	1.01e-05	9.63e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—HBA2—type 2 diabetes mellitus	1.01e-05	9.63e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—MTR—type 2 diabetes mellitus	1.01e-05	9.61e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—CPT1A—type 2 diabetes mellitus	1.01e-05	9.61e-05	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—PPARGC1A—type 2 diabetes mellitus	9.98e-06	9.48e-05	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—GNB3—type 2 diabetes mellitus	9.98e-06	9.48e-05	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—HMOX1—type 2 diabetes mellitus	9.94e-06	9.44e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—NAMPT—type 2 diabetes mellitus	9.93e-06	9.43e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—HBA1—type 2 diabetes mellitus	9.87e-06	9.37e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—LIPC—type 2 diabetes mellitus	9.87e-06	9.37e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—GCK—type 2 diabetes mellitus	9.87e-06	9.37e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—GCGR—type 2 diabetes mellitus	9.82e-06	9.33e-05	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—CAT—type 2 diabetes mellitus	9.8e-06	9.31e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—CYP11A1—type 2 diabetes mellitus	9.8e-06	9.31e-05	CbGpPWpGaD
L-Carnitine—SLC22A8—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	9.79e-06	9.29e-05	CbGpPWpGaD
L-Carnitine—SLC22A8—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	9.74e-06	9.25e-05	CbGpPWpGaD
L-Carnitine—SLC22A8—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	9.65e-06	9.17e-05	CbGpPWpGaD
L-Carnitine—SLC22A5—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	9.64e-06	9.16e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—SLC9A1—type 2 diabetes mellitus	9.63e-06	9.14e-05	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—PPARG—type 2 diabetes mellitus	9.57e-06	9.09e-05	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—APOB—type 2 diabetes mellitus	9.52e-06	9.04e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—CETP—type 2 diabetes mellitus	9.52e-06	9.04e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—CYP1A2—type 2 diabetes mellitus	9.46e-06	8.98e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Transmembrane transport of small molecules—PLAT—type 2 diabetes mellitus	9.43e-06	8.95e-05	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—INS—type 2 diabetes mellitus	9.39e-06	8.92e-05	CbGpPWpGaD
L-Carnitine—SLC22A8—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	9.33e-06	8.86e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—OXCT1—type 2 diabetes mellitus	9.28e-06	8.81e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—CYTB—type 2 diabetes mellitus	9.28e-06	8.81e-05	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—GSTM1—type 2 diabetes mellitus	9.26e-06	8.79e-05	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—LPL—type 2 diabetes mellitus	9.09e-06	8.63e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—SRD5A1—type 2 diabetes mellitus	9.04e-06	8.59e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	8.99e-06	8.54e-05	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—ADCY5—type 2 diabetes mellitus	8.9e-06	8.45e-05	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—GPX1—type 2 diabetes mellitus	8.87e-06	8.42e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—PSMD6—type 2 diabetes mellitus	8.85e-06	8.4e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—SREBF1—type 2 diabetes mellitus	8.85e-06	8.4e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—SNAP25—type 2 diabetes mellitus	8.85e-06	8.4e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—SLC-mediated transmembrane transport—ALB—type 2 diabetes mellitus	8.74e-06	8.3e-05	CbGpPWpGaD
L-Carnitine—SLC22A8—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	8.72e-06	8.28e-05	CbGpPWpGaD
L-Carnitine—SLC22A5—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	8.7e-06	8.26e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—CTGF—type 2 diabetes mellitus	8.69e-06	8.25e-05	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—CD36—type 2 diabetes mellitus	8.64e-06	8.2e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—STAR—type 2 diabetes mellitus	8.62e-06	8.19e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—HSD17B3—type 2 diabetes mellitus	8.62e-06	8.19e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—ACACA—type 2 diabetes mellitus	8.62e-06	8.19e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	8.62e-06	8.19e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—HMGCR—type 2 diabetes mellitus	8.61e-06	8.17e-05	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—ALB—type 2 diabetes mellitus	8.61e-06	8.17e-05	CbGpPWpGaD
L-Carnitine—SLC22A4—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	8.6e-06	8.17e-05	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—PPP2CA—type 2 diabetes mellitus	8.53e-06	8.1e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—ADRA2A—type 2 diabetes mellitus	8.42e-06	8e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—CBS—type 2 diabetes mellitus	8.27e-06	7.85e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—ABCC8—type 2 diabetes mellitus	8.27e-06	7.85e-05	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—NOS3—type 2 diabetes mellitus	8.23e-06	7.82e-05	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—PIK3R1—type 2 diabetes mellitus	8.23e-06	7.82e-05	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—MTHFR—type 2 diabetes mellitus	8.18e-06	7.77e-05	CbGpPWpGaD
L-Carnitine—SLC22A5—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	8.16e-06	7.75e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—CYP2E1—type 2 diabetes mellitus	8.09e-06	7.69e-05	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—PPARA—type 2 diabetes mellitus	8.03e-06	7.62e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—SLC2A1—type 2 diabetes mellitus	8e-06	7.6e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—CYP1A2—type 2 diabetes mellitus	8e-06	7.6e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—SLC5A2—type 2 diabetes mellitus	7.96e-06	7.56e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—COX2—type 2 diabetes mellitus	7.96e-06	7.56e-05	CbGpPWpGaD
L-Carnitine—SLC22A8—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	7.87e-06	7.47e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—NCOA6—type 2 diabetes mellitus	7.82e-06	7.43e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—PPARGC1A—type 2 diabetes mellitus	7.81e-06	7.42e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—CYP3A4—type 2 diabetes mellitus	7.8e-06	7.41e-05	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—AGT—type 2 diabetes mellitus	7.78e-06	7.38e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—UCP3—type 2 diabetes mellitus	7.69e-06	7.3e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—UCP2—type 2 diabetes mellitus	7.69e-06	7.3e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—HSD11B1—type 2 diabetes mellitus	7.69e-06	7.3e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—GCG—type 2 diabetes mellitus	7.67e-06	7.29e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—SLC2A4—type 2 diabetes mellitus	7.67e-06	7.29e-05	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—CALM1—type 2 diabetes mellitus	7.65e-06	7.26e-05	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—APOE—type 2 diabetes mellitus	7.62e-06	7.23e-05	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—PTGS2—type 2 diabetes mellitus	7.53e-06	7.15e-05	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—APOA1—type 2 diabetes mellitus	7.53e-06	7.15e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—APOB—type 2 diabetes mellitus	7.45e-06	7.08e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	7.43e-06	7.06e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	7.4e-06	7.02e-05	CbGpPWpGaD
L-Carnitine—SLC22A8—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	7.38e-06	7.01e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	7.33e-06	6.96e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—PCK1—type 2 diabetes mellitus	7.23e-06	6.86e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	7.11e-06	6.76e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	7.09e-06	6.73e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	6.94e-06	6.59e-05	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—AKT1—type 2 diabetes mellitus	6.91e-06	6.56e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—HK1—type 2 diabetes mellitus	6.77e-06	6.43e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	6.76e-06	6.42e-05	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—PPARG—type 2 diabetes mellitus	6.64e-06	6.3e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	6.62e-06	6.29e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—PPARGC1A—type 2 diabetes mellitus	6.61e-06	6.28e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—GNB3—type 2 diabetes mellitus	6.61e-06	6.28e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—HMOX1—type 2 diabetes mellitus	6.58e-06	6.25e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—GCKR—type 2 diabetes mellitus	6.54e-06	6.21e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—HSD3B2—type 2 diabetes mellitus	6.54e-06	6.21e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—KCNJ11—type 2 diabetes mellitus	6.54e-06	6.21e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—LPA—type 2 diabetes mellitus	6.54e-06	6.21e-05	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—INS—type 2 diabetes mellitus	6.51e-06	6.18e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—CAT—type 2 diabetes mellitus	6.49e-06	6.17e-05	CbGpPWpGaD
L-Carnitine—SLC22A5—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	6.47e-06	6.14e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—APOB—type 2 diabetes mellitus	6.31e-06	5.99e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	6.28e-06	5.97e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—ALDOB—type 2 diabetes mellitus	6.27e-06	5.95e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—GSTM1—type 2 diabetes mellitus	6.13e-06	5.82e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	6.09e-06	5.78e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—LPL—type 2 diabetes mellitus	6.02e-06	5.72e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	5.98e-06	5.68e-05	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—ALB—type 2 diabetes mellitus	5.97e-06	5.67e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	5.96e-06	5.66e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	5.9e-06	5.6e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—ADCY5—type 2 diabetes mellitus	5.89e-06	5.6e-05	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—AKT1—type 2 diabetes mellitus	5.87e-06	5.58e-05	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—AKT1—type 2 diabetes mellitus	5.87e-06	5.58e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—GPX1—type 2 diabetes mellitus	5.87e-06	5.58e-05	CbGpPWpGaD
L-Carnitine—SLC22A8—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	5.85e-06	5.55e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—GLP1R—type 2 diabetes mellitus	5.83e-06	5.53e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—CD36—type 2 diabetes mellitus	5.72e-06	5.43e-05	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—PIK3R1—type 2 diabetes mellitus	5.71e-06	5.42e-05	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—NOS3—type 2 diabetes mellitus	5.71e-06	5.42e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—PPP2CA—type 2 diabetes mellitus	5.65e-06	5.36e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	5.61e-06	5.32e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—SLC2A2—type 2 diabetes mellitus	5.44e-06	5.16e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—MTHFR—type 2 diabetes mellitus	5.42e-06	5.15e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—CPT1A—type 2 diabetes mellitus	5.33e-06	5.06e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—MTR—type 2 diabetes mellitus	5.33e-06	5.06e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—PPARA—type 2 diabetes mellitus	5.32e-06	5.05e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—NAMPT—type 2 diabetes mellitus	5.23e-06	4.96e-05	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—PTGS2—type 2 diabetes mellitus	5.22e-06	4.96e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	5.19e-06	4.93e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—GCK—type 2 diabetes mellitus	5.19e-06	4.93e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—HBA1—type 2 diabetes mellitus	5.19e-06	4.93e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—LIPC—type 2 diabetes mellitus	5.19e-06	4.93e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—CYP11A1—type 2 diabetes mellitus	5.16e-06	4.9e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—AGT—type 2 diabetes mellitus	5.15e-06	4.89e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—SLC9A1—type 2 diabetes mellitus	5.07e-06	4.81e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—CALM1—type 2 diabetes mellitus	5.06e-06	4.81e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—APOE—type 2 diabetes mellitus	5.05e-06	4.79e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—CETP—type 2 diabetes mellitus	5.01e-06	4.76e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—APOA1—type 2 diabetes mellitus	4.99e-06	4.74e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	4.67e-06	4.44e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—PSMD6—type 2 diabetes mellitus	4.66e-06	4.42e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—SREBF1—type 2 diabetes mellitus	4.66e-06	4.42e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—SNAP25—type 2 diabetes mellitus	4.66e-06	4.42e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—CTGF—type 2 diabetes mellitus	4.57e-06	4.34e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—HMGCR—type 2 diabetes mellitus	4.53e-06	4.3e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	4.47e-06	4.24e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	4.44e-06	4.22e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—ADRA2A—type 2 diabetes mellitus	4.43e-06	4.21e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—PPARG—type 2 diabetes mellitus	4.4e-06	4.17e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—INS—type 2 diabetes mellitus	4.31e-06	4.09e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—CYP2E1—type 2 diabetes mellitus	4.26e-06	4.05e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—CYP1A2—type 2 diabetes mellitus	4.21e-06	4e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—SLC2A1—type 2 diabetes mellitus	4.21e-06	4e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—CYP3A4—type 2 diabetes mellitus	4.11e-06	3.9e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	4.09e-06	3.88e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—SLC2A4—type 2 diabetes mellitus	4.04e-06	3.83e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—GCG—type 2 diabetes mellitus	4.04e-06	3.83e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—ALB—type 2 diabetes mellitus	3.95e-06	3.75e-05	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—AKT1—type 2 diabetes mellitus	3.78e-06	3.59e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—PIK3R1—type 2 diabetes mellitus	3.78e-06	3.59e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—NOS3—type 2 diabetes mellitus	3.78e-06	3.59e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—GNB3—type 2 diabetes mellitus	3.48e-06	3.31e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.48e-06	3.31e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—HMOX1—type 2 diabetes mellitus	3.46e-06	3.29e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—PTGS2—type 2 diabetes mellitus	3.46e-06	3.28e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—CAT—type 2 diabetes mellitus	3.42e-06	3.25e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—APOB—type 2 diabetes mellitus	3.32e-06	3.15e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—GSTM1—type 2 diabetes mellitus	3.23e-06	3.07e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—LPL—type 2 diabetes mellitus	3.17e-06	3.01e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—ADCY5—type 2 diabetes mellitus	3.1e-06	2.95e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—GPX1—type 2 diabetes mellitus	3.09e-06	2.94e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—CD36—type 2 diabetes mellitus	3.01e-06	2.86e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—PPP2CA—type 2 diabetes mellitus	2.97e-06	2.82e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—MTHFR—type 2 diabetes mellitus	2.85e-06	2.71e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—PPARA—type 2 diabetes mellitus	2.8e-06	2.66e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—AGT—type 2 diabetes mellitus	2.71e-06	2.57e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—CALM1—type 2 diabetes mellitus	2.67e-06	2.53e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—APOE—type 2 diabetes mellitus	2.66e-06	2.52e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—APOA1—type 2 diabetes mellitus	2.63e-06	2.49e-05	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—AKT1—type 2 diabetes mellitus	2.62e-06	2.49e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—PPARG—type 2 diabetes mellitus	2.31e-06	2.2e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—INS—type 2 diabetes mellitus	2.27e-06	2.15e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—ALB—type 2 diabetes mellitus	2.08e-06	1.98e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—PIK3R1—type 2 diabetes mellitus	1.99e-06	1.89e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—NOS3—type 2 diabetes mellitus	1.99e-06	1.89e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—PTGS2—type 2 diabetes mellitus	1.82e-06	1.73e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—AKT1—type 2 diabetes mellitus	1.74e-06	1.65e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—AKT1—type 2 diabetes mellitus	9.15e-07	8.69e-06	CbGpPWpGaD
